Table 4.

Treatment Delivery

	Dose Level
	Level 1 (30 + 30)	Level 2 (30 + 50)	Level 3 (50 + 50)	All
Disposition During Treatment
No. registered	13	19	14	46
No. evaluable for toxicity	11	12	12	35
Diagnosis , no.
Indolent B-Cell NHL	3	3	6	12
Intermediate Grade B-NHL	2	3	6	11
Mantle Cell Lymphoma	3	3	0	6
T/NK-Cell NHL	3	3	0	6
Median Cycles Received (range)	3 (1–6)	2 (0–6)	2 (0–6)	2 (0–6)
Median doses received (range)	12 (4–24)	8 (2–24)	8 (3–24)	8 (2–24)
Reason for Discontinuing Therapy
Completed all planned therapy	3 (27)	1 (8)	1 (8)	5 (14)
Adverse Event	0 (0)	2 (17)	3 (25)	5 (14)
Disease Progression	6 (55)	7 (58)	7 (58)	20 (57)
Death	0 (0)	1 (8)	0 (0)	1 (3)
Proceeded to transplant	0 (0)	1 (8)	0 (0)	1 (3)
Other	2 (18)	0 (0)	1 (8)	3 (9)